Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |